Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases
Sponsor: Assistance Publique Hopitaux De Marseille
Summary
This study aims to answer a key question in the field of rare genetic diseases by determining the prevalence of deleterious variants at RNA level in undiagnosed patients with intellectual disability and/or neonatal hypotonia. This study will put an end to diagnostic erraticism in a number of patients. Finally, the results of this study will make it possible to compare the two types of tissue used for RNAseq, with a view to facilitating the implementation of this analysis method in the diagnostic setting.
Official title: Transcriptomic Analysis (RNAseq) of Blood and Fibroblasts to Establish a Diagnosis in Patients With Rare Diseases
Key Details
Gender
All
Age Range
0 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2025-12-15
Completion Date
2029-04-30
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
Blood collection
Blood is collected in order to perform transcriptomic sequencing from blood
skin biopsy
A biopsy of skin is performed in order to perform transcriptomic sequencing on fibroblasts obtained from the biopsy
Locations (1)
Assistance publique - hôpitaux de Marseille
Marseille, Provence-Alpes-Côt-d'Azue, France